Tirzepatide is the first in this class to receive FDA approval, and it targets both the GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) receptors
Your provider can help you figure out what applies to your situation
In people who are overweight or obese, the SELECT study showed a significant decrease in major adverse cardiovascular events (MACE), including heart attacks, strokes, and cardiovascular deaths
Medicare spends billions of dollars each year treating heart disease, diabetes, kidney disease, cancer and other illnesses caused or worsened by obesity
Once I was on Ozempic, I stopped doing that." Less addictive behaviours was a common effect experienced by weight loss drug users Overall impact on cravings and addictive behaviors "I stopped picking the cuticles around my fingernails," said 45-year-old John, a change he certainly didnt expect when he started Ozempic, "I used to pick at it a lot